IMTX
Immatics N.V

913
Loading...
Loading...
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
423

Frequently Asked Questions

What is Market Cap of Immatics N.V?
What is the 52-week high for Immatics N.V?
What is the 52-week low for Immatics N.V?
What is Immatics N.V stock price today?
What was Immatics N.V stock price yesterday?
What is the PE ratio of Immatics N.V?
What is the Price-to-Book ratio of Immatics N.V?
What is the 50-day moving average of Immatics N.V?
How many employess does Immatics N.V has?

Latest IMTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.